ISRG · Full Picture
INTUITIVE SURGICAL INC — the full picture
Trailing window · 2026-05-11 to 2026-08-09
One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.
What to look at first
- Revenue Performance and Mix · Revenue growth & mixPriority 65+15.5% revenue (realized); quote_verifiedIntuitive Surgical reported quarterly earnings of $2.80 EPS and revenue of $2.89 billion, an 18.4% year-over-year increase.
- Competition and New Entrants · Competition & market sharePriority 371 forward row(s); quote_verifiedMedtronic's Touch Surgery Aide platform received FDA clearance for its first AI algorithm, Instrument Exit Point (IEP).
- Competition and Market Share · Competition & market sharePriority 36quote_verifiedSimply Wall Street reported Intuitive Surgical had a 7.21% gain over the past week but a 32.59% year-to-date decline, with a fair value pegged at $630.48 against a current share price of $378.81 and a P/E ratio of 42.6x.
- Guidance / Outlook · Guidance & outlookPriority 36quote_verifiedPluang stated the decline in Intuitive Surgical's stock was attributed to slower-than-expected growth guidance.
- Product Safety Recall · UnclassifiedPriority 31quote_verifiedIntuitive Surgical is facing a Class II recall of over 11,000 da Vinci SP Instrument Arm Drapes.
- Product Launch and Transition · Products & launchesPriority 30quote_verifiedIntuitive Surgical's da Vinci 5 is gaining rapid adoption and is fueling hospital upgrades as software enhancements build a potential multi-year capital cycle.
- Trade Policy and Tariffs · Tariffs & trade policyPriority 25quote_verifiedPluang reported Intuitive Surgical stock is trading 28% below its average Wall Street target price and is down 34% year-to-date, citing tariff pressures as a cause.
Threads by pillar
Revenue & Demand Priority 66 · 2 threads
- Revenue Performance and MixPriority 65 · News
- Product Launch and TransitionPriority 30 · News
Legal, Regulatory & Policy Priority 25 · 1 thread
- Trade Policy and TariffsPriority 25 · News
Guidance & Outlook Priority 36 · 1 thread
- Guidance / OutlookPriority 36 · News
Macro & Market Conditions Priority 40 · 2 threads
- Competition and New EntrantsPriority 37 · News
- Competition and Market SharePriority 36 · News
Unclassified Priority 31 · 1 thread
- Product Safety RecallPriority 31 · News
Expected impact by metric
| metric | forward net | forward gross | realized |
|---|---|---|---|
| revenue | — | — | +15.5% |